Month: March 2016

Home » Archives for March 2016

Prostate Cancer Treatment Inconsistencies Found In Canada

The Canadian Partnership Against Cancer said data suggests three-quarters of men with low-risk prostate cancer in Manitoba and Prince Edward Island opted for active surveillance. In contrast, more than half of low-risk prostate cancer patients in British Columbia, Alberta, Saskatchewan and Nova Scotia were treated with surgery, radiation, or a combination, treatments with possible side-effects that include erectile dysfunction and incontinence. Read the article.

Prostate Cancer Treatment Inconsistencies Found In Canada Read More »

Prostate cancer plummets: Incidence and mortality rates in free fall

The American age-adjusted incidence rate for prostate cancer peaked in 1992 at 237.4 per 100,000 men with the advent of widespread PSA screening and has been falling fast ever since. The age-adjusted mortality rate for prostate cancer peaked in 1993 — just a year after the incidence rate did — at 39.3 per 100,000 men. Explanations for the decline in the mortality rate range from improvements in treatment to American men having healthier diets. Advocates of screening say early detection has also had a hand in bending the mortality-rate curve. Read the article.

Prostate cancer plummets: Incidence and mortality rates in free fall Read More »

Video: Dr. Shabbir Alibhai, “Understanding, preventing and managing side effects of hormone therapy.”

January 2016 Awareness Night   Understanding, preventing and managing side effects of hormone therapy. Dr. Shabbir Alibhai,MSc, MD, FRCPC,Princess Margaret Cancer Centre Senior Scientist, Toronto General Research Institute (TGRI) Scientist, Toronto Rehabilitation Institute (TRI) Asst Prof, Depts of Medicine and Health Policy, Management, and Evaluation at the U of Toronto CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation 43:32 minutes

Video: Dr. Shabbir Alibhai, “Understanding, preventing and managing side effects of hormone therapy.” Read More »

Scroll to Top